Oracle (NYSE:ORCL - Get Free Report) had its price objective increased by stock analysts at TD Cowen from $250.00 to $275.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has a "buy" rating on the enterprise software provider's stock. TD Cowen's price target would suggest a potential upside of 15.84% from the stock's previous close.
Several other equities analysts have also commented on the company. The Goldman Sachs Group restated a "neutral" rating and set a $195.00 price target (up previously from $145.00) on shares of Oracle in a research note on Friday, June 13th. Raymond James Financial restated a "strong-buy" rating on shares of Oracle in a research note on Wednesday, June 18th. UBS Group set a $250.00 target price on Oracle and gave the company a "buy" rating in a research note on Wednesday, June 25th. Jefferies Financial Group lifted their target price on Oracle from $190.00 to $200.00 and gave the company a "buy" rating in a research note on Monday, June 9th. Finally, Guggenheim lifted their target price on Oracle from $220.00 to $250.00 and gave the company a "buy" rating in a research note on Wednesday, June 18th. Ten analysts have rated the stock with a hold rating, twenty-two have given a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $204.15.
Get Our Latest Stock Report on Oracle
Oracle Trading Up 3.2%
ORCL stock traded up $7.41 during midday trading on Thursday, reaching $237.39. The company's stock had a trading volume of 18,441,376 shares, compared to its average volume of 10,159,668. The company has a debt-to-equity ratio of 4.07, a quick ratio of 0.75 and a current ratio of 0.75. The stock has a fifty day simple moving average of $178.14 and a two-hundred day simple moving average of $164.22. Oracle has a 1 year low of $118.86 and a 1 year high of $237.99. The firm has a market capitalization of $666.79 billion, a price-to-earnings ratio of 54.70, a PEG ratio of 3.55 and a beta of 1.39.
Oracle (NYSE:ORCL - Get Free Report) last announced its quarterly earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 EPS for the quarter, beating the consensus estimate of $1.64 by $0.06. The firm had revenue of $15.90 billion for the quarter, compared to analyst estimates of $15.58 billion. Oracle had a return on equity of 87.34% and a net margin of 21.68%. The business's revenue for the quarter was up 11.3% on a year-over-year basis. During the same quarter last year, the firm posted $1.63 earnings per share. On average, equities research analysts predict that Oracle will post 5 EPS for the current year.
Insider Buying and Selling
In related news, Director Leon E. Panetta sold 17,500 shares of Oracle stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $151.24, for a total transaction of $2,646,700.00. Following the completion of the transaction, the director directly owned 58,090 shares in the company, valued at approximately $8,785,531.60. This trade represents a 23.15% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Clayton M. Magouyrk sold 15,000 shares of Oracle stock in a transaction that occurred on Tuesday, June 17th. The shares were sold at an average price of $214.10, for a total value of $3,211,500.00. Following the transaction, the insider owned 60,722 shares of the company's stock, valued at approximately $13,000,580.20. This represents a 19.81% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 440,366 shares of company stock valued at $83,103,603 in the last ninety days. Insiders own 42.20% of the company's stock.
Institutional Trading of Oracle
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Trinity Financial Advisors LLC purchased a new stake in shares of Oracle in the second quarter valued at approximately $270,000. Arvest Investments Inc. purchased a new stake in shares of Oracle in the second quarter valued at approximately $682,000. TrueWealth Advisors LLC increased its position in shares of Oracle by 2.3% in the second quarter. TrueWealth Advisors LLC now owns 5,221 shares of the enterprise software provider's stock valued at $1,142,000 after buying an additional 117 shares in the last quarter. McLean Asset Management Corp increased its position in shares of Oracle by 2.0% in the second quarter. McLean Asset Management Corp now owns 5,283 shares of the enterprise software provider's stock valued at $1,215,000 after buying an additional 106 shares in the last quarter. Finally, Sage Capital Advisors llc purchased a new stake in shares of Oracle in the second quarter valued at approximately $5,793,000. 42.44% of the stock is currently owned by hedge funds and other institutional investors.
About Oracle
(
Get Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Featured Stories

Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.